United-Guardian IncNASDAQ:UG
- LAST PRICE8.0662
- TODAY'S CHANGE (%)-0.0567 (-0.6980%)
- Bid / Lots7.9000/ 2
- Ask / Lots8.2000/ 2
- Open / Previous Close8.1999 / 8.1229
- Day Range
- 52 Week Range
- Volume5,382
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | UG |
|---|---|---|
| 10:18 ET | 514 | 8.1999 |
| 11:12 ET | 200 | 8.1089 |
| 12:14 ET | 534 | 8.175 |
| 12:15 ET | 199 | 8.2 |
| 12:17 ET | 300 | 8.165 |
| 12:19 ET | 374 | 8.1999 |
| 12:21 ET | 835 | 8.15 |
| 12:55 ET | 500 | 8.15 |
| 03:28 ET | 150 | 8.135 |
| 03:33 ET | 500 | 8.01 |
| 03:37 ET | 105 | 8.0662 |
Nov 6, 2023
*DJ United-Guardian 3Q EPS 14c >UG, from 9:00AM ET on Monday Nov 06, 2023 by Dow Jones
9:00AM ET on Monday Nov 06, 2023 by Dow JonesUnited-Guardian Reports Increased Third Quarter Sales & Earnings, from 9:00AM ET on Monday Nov 06, 2023 by Dow Jones
9:00AM ET on Monday Nov 06, 2023 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
United-Guardian Inc | 37.1M | 14.7x | -7.84% |
HOOKIPA Pharma Inc | 48.3M | -0.6x | --- |
Rapid Micro Biosystems Inc | 47.5M | -0.8x | --- |
Equillium Inc | 18.7M | -2.2x | --- |
Guardion Health Sciences Inc | 7.6M | -0.7x | --- |
Sonoma Pharmaceuticals Inc | 2.4M | -0.1x | --- |
Company Information
United-Guardian, Inc. is engaged in manufacturing and marketing of cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its cosmetic ingredients products include Lubrajel, Lubrajel Natural and Lubrajel Marine, B-122, Orchid Complex and Lubrasil II SB. Its other products in the Lubrajel Natural line of Lubrajel products are: Lubrajel Oll Natural and Lubrajel Terra. Its medical lubricants products include Lubrajel MG, Lubrajel MGL, Lubrajel RR and RC, Lubrajel Fluid and Lubrajel LC, Lubrajel BA and Lubrajel FA. Its pharmaceuticals products include Renacidin, which is a prescription drug that is used to prevent and to dissolve calcifications in urethral catheters, and CLORPACTIN WCS-90, which is a chlorine-based drug that is marketed as a topical antimicrobial and is also used in urology. Its industrial products consist of Deselex, which is a sequestering and chelating agent, and Thoroclens, which is a chlorine-based industrial cleanse.
Contact Information
- Headquarters
- 230 Marcus BlvdHAUPPAUGE, NY, United States 11788-3731
- Phone
- 631-273-0900
- Fax
- 631-273-0858
Executives
- Chairman of the Board
- Kenneth Globus
- President
- Donna Vigilante
- Principal Financial Officer, Controller, Treasurer, Secretary
- Andrea Young
- Senior Vice President, Production Manager
- Peter Hiltunen
- Independent Director
- Andrew Boccone
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $37.1M |
|---|---|
Revenue (TTM) | $11.0M |
Shares Outstanding | 4.6M |
Dividend Yield | 5.08% |
Annual Dividend Rate | 0.4100 USD |
Ex-Dividend Date | 07-25-23 |
Pay Date | 08-02-23 |
Beta | 0.74 |
EPS | $0.55 |
Book Value | $2.02 |
P/E Ratio | 14.7x |
Price/Sales (TTM) | 3.4 |
Price/Cash Flow (TTM) | 14.1x |
Operating Margin | 24.61% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
